Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OZURDEX safely and effectively. See full prescribing information for OZURDEX. OZURDEX ® (dexamethasone intravitreal implant) , f or i ntravitreal i njection Initial U.S. Approval: 1958
Medication labelWhy this: Advisory · dailymed-prescription
OZURDEX® (dexamethasone intravitreal implant) is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). OZURDEX is indicated for the treatment of non-infectious uveitis affecting the posterior segment of the eye. OZURDEX is indicated for the treatment of diabetic macular edema.
- generic_name
- dexamethasone
- product_names
- dexamethasone
- ndc
- 0023-3348, 0023-3348-07, 0023-3348-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en